Pharming Group NV (PHAR) Social Stream

Pharming Group NV (PHAR): $8.60

0.29 (+3.49%)

POWR Rating

Component Grades













Add PHAR to Watchlist
Sign Up

Industry: Biotech


of 481

in industry

Pharming Group NV (PHAR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PHAR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-16 2 $43 $43 $43 $7.76 454.12%
2021-08-16 1 $43 $43 $43 $7.76 454.12%

PHAR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • PHAR has a lower variance in analysts' estimates than just about 100% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Pharming Group NV's number of analysts covering the stock is higher than 5.29% of them.
  • In the context of stocks in the small market cap category, Pharming Group NV's upside potential (average analyst target price relative to current price) is higher than 179.54% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Pharming Group NV's average analyst price target is higher than 164.38% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Pharming Group NV are PDSB, OVID, and OTIC.

Make investment decisions regarding PHAR using the data that counts. Try POWR Ratings for free.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.607 seconds.